Divi's Laboratories announces the establishment of new Solid Phase Peptide Synthesis (SPPS) lines to cater to increasing ...
Boehringer Ingelheim and Zealand Pharma's obesity drug, Survodutide, shows no increased heart risk and significant weight loss in a late-stage trial, paving the way for global regulatory approval.
Eli Lilly's Phase 3 trial reveals that its weight-loss pill Foundayo effectively reduces obstructive sleep apnea severity, ...
The US FDA has mandated new warnings for GLP-1 medications, including Ozempic and Zepbound, regarding a potential eye ...
AstraZeneca strengthens its vaccine pipeline by acquiring early-stage biotech firm Omniose, which specializes in developing ...
Hyderabad: Amgen has opened a new technology and innovation site in Hyderabad, named Amgen India. The company plans to invest $200 million by 2025, with further investments anticipated in the future.
New Delhi: Hyderabad-based Dr Reddy’s Laboratories is set to launch its semaglutide generic in Canada while expanding its India portfolio with the rollout of an oral pill this month. “We are preparing ...
Mumbai: Drugmaker Lupin Limited ha launched raltegravir tablets in the US, following the approval of its Abbreviated New Drug ...
Zura Bio announces the failure of its experimental drug tibulizumab in a mid-stage trial for treating hidradenitis ...
BDR Pharmaceuticals has acquired a controlling stake in Acme Formulations' oral solid formulations division, enhancing its ...
ETPharma.com brings latest dr reddy s laboratories news, views and updates from all top sources for the Indian Pharma industry.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results